Chronic myeloid leukemia CD34+ cells have elevated levels of phosphatidylinositol 3,4,5 trisphosphate (PtdIns(3,4,5)P3) and lack a PtdIns(3,4,5)P3 response to cytokines and chemotactic factors; effects reversed by imatinib [9]

H. G. Hamzah; A. Pierce; W. A. Stewart; C. Peter  Downes; A. Gray; A. Irvine; E. Spooncer; A. D. Whetton

doi:10.1038/sj.leu.2403919

Chronic myeloid leukemia CD34+ cells have elevated levels of phosphatidylinositol 3,4,5 trisphosphate (PtdIns(3,4,5)P₃) and lack a PtdIns(3,4,5)P₃ response to cytokines and chemotactic factors; effects reversed by imatinib [9]

H. G. Hamzah
, A. Pierce
, W. A. Stewart
, C. Peter Downes
, A. Gray
, A. Irvine
, E. Spooncer
, A. D. Whetton

Biological Chemistry and Drug Discovery

Research output: Contribution to journal › Letter › peer-review

5 Citations (Scopus)

Original language	English
Pages (from-to)	1851-1853
Number of pages	3
Journal	Leukemia
Volume	19
Issue number	10
DOIs	https://doi.org/10.1038/sj.leu.2403919
Publication status	Published - 18 Aug 2005

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

ASJC Scopus subject areas

Hematology
Cancer Research
Anesthesiology and Pain Medicine

Access to Document

10.1038/sj.leu.2403919

Cite this

Hamzah, H. G., Pierce, A., Stewart, W. A., Downes, C. P., Gray, A., Irvine, A., Spooncer, E., & Whetton, A. D. (2005). Chronic myeloid leukemia CD34+ cells have elevated levels of phosphatidylinositol 3,4,5 trisphosphate (PtdIns(3,4,5)P₃) and lack a PtdIns(3,4,5)P₃ response to cytokines and chemotactic factors; effects reversed by imatinib [9]. Leukemia, 19(10), 1851-1853. https://doi.org/10.1038/sj.leu.2403919

@article{c067a5f8a9cf4f5dbcab89e20465859f,

title = "Chronic myeloid leukemia CD34+ cells have elevated levels of phosphatidylinositol 3,4,5 trisphosphate (PtdIns(3,4,5)P3) and lack a PtdIns(3,4,5)P3 response to cytokines and chemotactic factors; effects reversed by imatinib [9]",

author = "Hamzah, \{H. G.\} and A. Pierce and Stewart, \{W. A.\} and Downes, \{C. Peter\} and A. Gray and A. Irvine and E. Spooncer and Whetton, \{A. D.\}",

year = "2005",

month = aug,

day = "18",

doi = "10.1038/sj.leu.2403919",

language = "English",

volume = "19",

pages = "1851--1853",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Springer Nature",

number = "10",

}

Hamzah, HG, Pierce, A, Stewart, WA, Downes, CP , Gray, A, Irvine, A, Spooncer, E & Whetton, AD 2005, 'Chronic myeloid leukemia CD34+ cells have elevated levels of phosphatidylinositol 3,4,5 trisphosphate (PtdIns(3,4,5)P₃) and lack a PtdIns(3,4,5)P₃ response to cytokines and chemotactic factors; effects reversed by imatinib [9]', Leukemia, vol. 19, no. 10, pp. 1851-1853. https://doi.org/10.1038/sj.leu.2403919

Chronic myeloid leukemia CD34+ cells have elevated levels of phosphatidylinositol 3,4,5 trisphosphate (PtdIns(3,4,5)P₃) and lack a PtdIns(3,4,5)P₃ response to cytokines and chemotactic factors; effects reversed by imatinib [9]. / Hamzah, H. G.; Pierce, A.; Stewart, W. A. et al.
In: Leukemia, Vol. 19, No. 10, 18.08.2005, p. 1851-1853.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Chronic myeloid leukemia CD34+ cells have elevated levels of phosphatidylinositol 3,4,5 trisphosphate (PtdIns(3,4,5)P3) and lack a PtdIns(3,4,5)P3 response to cytokines and chemotactic factors; effects reversed by imatinib [9]

AU - Hamzah, H. G.

AU - Pierce, A.

AU - Stewart, W. A.

AU - Downes, C. Peter

AU - Gray, A.

AU - Irvine, A.

AU - Spooncer, E.

AU - Whetton, A. D.

PY - 2005/8/18

Y1 - 2005/8/18

UR - https://www.scopus.com/pages/publications/27144454373

U2 - 10.1038/sj.leu.2403919

DO - 10.1038/sj.leu.2403919

M3 - Letter

C2 - 16107888

AN - SCOPUS:27144454373

SN - 0887-6924

VL - 19

SP - 1851

EP - 1853

JO - Leukemia

JF - Leukemia

IS - 10